Pharma-Bio Serv, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Pharma-Bio Serv, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Common Stock, Shares, Outstanding for the quarter ending July 31, 2024 was 23M shares, a 0.03% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 23M -6.11K -0.03% Jul 31, 2024 10-Q 2024-09-16
Q1 2024 23M -8.71K -0.04% Apr 30, 2024 10-Q 2024-06-14
Q4 2023 23M +12.8K +0.06% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 23M +20K +0.09% Oct 31, 2023 10-Q 2024-09-16
Q2 2023 23M +17.8K +0.08% Jul 31, 2023 10-Q 2023-09-14
Q1 2023 23M +12.5K +0.05% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 23M -22.9K -0.1% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 22.9M -60.1K -0.26% Oct 31, 2022 10-K 2024-01-29
Q2 2022 22.9M -82.7K -0.36% Jul 31, 2022 10-Q 2022-09-14
Q1 2022 23M -72.3K -0.31% Apr 30, 2022 10-Q 2022-06-14
Q4 2021 23M -56K -0.24% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 23M +1.99K +0.01% Oct 31, 2021 10-K 2023-01-30
Q2 2021 23M +27.6K +0.12% Jul 31, 2021 10-Q 2021-09-14
Q1 2021 23M +27.6K +0.12% Apr 30, 2021 10-Q 2021-06-14
Q4 2020 23M +27.6K +0.12% Jan 31, 2021 10-Q 2021-03-17
Q3 2020 23M +5.75K +0.03% Oct 31, 2020 10-K 2022-02-11
Q2 2020 23M +5.75K +0.03% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 23M +5.15K +0.02% Apr 30, 2020 10-Q 2020-06-15
Q4 2019 23M +5.54K +0.02% Jan 31, 2020 10-Q 2020-03-16
Q3 2019 23M -62.5K -0.27% Oct 31, 2019 10-K 2021-02-01
Q2 2019 23M -66.7K -0.29% Jul 31, 2019 10-Q 2019-09-16
Q1 2019 23M -66.1K -0.29% Apr 30, 2019 10-Q 2019-06-14
Q4 2018 23M -66.4K -0.29% Jan 31, 2019 10-Q 2019-03-18
Q3 2018 23.1M -31.2K -0.14% Oct 31, 2018 10-K 2020-01-29
Q2 2018 23.1M -39.4K -0.17% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 23.1M -39.4K -0.17% Apr 30, 2018 10-Q 2018-06-14
Q4 2017 23.1M -51K -0.22% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 23.1M +80.3K +0.35% Oct 31, 2017 10-K 2019-01-29
Q2 2017 23.1M +90.8K +0.39% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 23.1M +84.4K +0.37% Apr 30, 2017 10-Q 2017-06-14
Q4 2016 23.1M +85.6K +0.37% Jan 31, 2017 10-Q 2017-03-17
Q3 2016 23M -11.1K -0.05% Oct 31, 2016 10-K 2018-01-29
Q2 2016 23M -55.3K -0.24% Jul 31, 2016 10-Q 2016-09-14
Q1 2016 23M -56.6K -0.25% Apr 30, 2016 10-Q 2016-06-14
Q4 2015 23M -61.9K -0.27% Jan 31, 2016 10-Q 2016-03-16
Q3 2015 23M -13.5K -0.06% Oct 31, 2015 10-K 2017-01-31
Q2 2015 23.1M +19K +0.08% Jul 31, 2015 10-Q 2015-09-14
Q1 2015 23.1M +24.7K +0.11% Apr 30, 2015 10-Q 2015-06-15
Q4 2014 23.1M +46.8K +0.2% Jan 31, 2015 10-Q 2015-03-17
Q3 2014 23M +332K +1.46% Oct 31, 2014 10-K 2016-01-29
Q2 2014 23M +345K +1.52% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 23M +385K +1.7% Apr 30, 2014 10-Q 2014-06-16
Q4 2013 23M +378K +1.67% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 22.7M +1.94M +9.36% Oct 31, 2013 10-K 2015-01-29
Q2 2013 22.7M +1.94M +9.36% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 22.7M +1.91M +9.18% Apr 30, 2013 10-Q 2013-06-14
Q4 2012 22.7M +1.91M +9.18% Jan 31, 2013 10-Q 2013-03-18
Q3 2012 20.8M 0 0% Oct 31, 2012 10-K 2014-01-29
Q2 2012 20.8M 0 0% Jul 31, 2012 10-Q 2012-09-14
Q1 2012 20.8M Apr 30, 2012 10-Q 2012-06-14
Q4 2011 20.8M Jan 31, 2012 10-Q 2012-03-16
Q3 2011 20.8M +7.48K +0.04% Oct 31, 2011 10-K 2013-01-29
Q2 2011 20.8M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 20.8M Oct 31, 2010 10-K/A 2012-01-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.